logo

Insmed Inc (INSM)



Trade INSM now with
  Date
  Headline
5/24/2019 11:59:39 AM Insmed Announces Closing Of Public Offering Of Common Stock
5/20/2019 4:06:30 PM Insmed Announces Proposed Public Offering Of Common Stock
5/7/2019 7:39:10 AM Insmed Q1 Net Loss $74.2 Mln Or $0.96/Shr Vs Loss Of $68.5 Mln Or $0.89/Shr Last Year
4/8/2019 5:01:44 AM Insmed Provides Update On ARIKAYCE U.S. Launch
4/2/2019 4:08:50 PM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2/22/2019 7:39:48 AM Insmed Q4 Net Loss $91.6 Mln Or $1.19/Shr Vs Loss Of $65.4 Mln Or $0.85/Shr Last Year
11/8/2018 8:35:01 AM Insmed Announces Several Changes To Board; Donald Hayden Steps Down As Chairman
10/30/2018 7:39:05 AM Insmed Q3 Net Loss $87.7 Mln Or $1.14/shr Vs. Net Loss $45.2 Mln Or $0.69/shr Last Year
10/11/2018 8:33:38 AM Insmed Presents Additional Data From Clinical Trials Of ARIKAYCE
9/17/2018 8:20:46 AM Insmed Says Pivotal Phase 3 Data From CONVERT Study Of ALIS Published
8/7/2018 5:33:59 PM Insmed Says FDA Advisory Committee Votes 12-2 In Favor Of Safety And Effectiveness Of ALIS
8/2/2018 7:43:41 AM Insmed Q2 Net Loss $76.4 Mln Vs. Net Loss $44.7 Mln Last Year